Skip to main content
Log in

Pharmacokinetic and Tissue Distribution Mechanism of Mouse Recombinant Heat Shock Protein 70 in Mice

  • Research Papers
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

No Heading

Purpose.

To investigate the in vivo pharmacokinetics and uptake mechanisms of recombinant mouse heat shock protein 70 (Hsp70) by hepatocytes in mice.

Methods.

The tissue distribution and intrahepatic localization of Hsp70 were determined after an intravenous injection of 111In-Hsp70 (111In-Hsp70) into mice. Ligands of CD91 or scavenger receptors were injected prior to Hsp70 to examine the involvement of these molecules on the distribution of 111In-Hsp70. The uptake of 111In-Hsp70 by primary mouse hepatocytes was also examined.

Results.

After intravenous injection, 111In-Hsp70 was rapidly eliminated from the circulation and taken up mainly by the liver. The hepatic uptake was significantly inhibited by preinjection of ligands for CD91 or scavenger receptors. The separation of liver-constituting cells revealed a major contribution of hepatocytes to the overall hepatic uptake of 111In-Hsp70. The uptake of 111In-Hsp70 by cultured hepatocytes was inhibited by a CD91 ligand or anti-CD91 anibody. In addition, after subcutaneous injection, 111In-Hsp70 gradually disappeared from the injection site and accumulated in primary lymph nodes.

Conclusions.

These results indicate for the first time that intravenous Hsp70 is, at least partially, recognized by CD91 and eliminated by hepatocytes, whereas subcutaneous Hsp70 is efficiently delivered to regional lymph nodes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

α2-M:

α2-macrogrobulin

AUC:

the area under plasma concentration-time curve

CL:

clearance

DTPA:

diethylenetriaminepentaacetic acid

Hsp70:

heat shock protein 70

PAGE:

polyacrylamide gel electrophoresis

References

  1. 1. B. Bukau and A. L. Horwich. The Hsp70 and Hsp60 chaperone machines. Cell 92:351–366 (1998).

    Article  CAS  PubMed  Google Scholar 

  2. 2. J. E. Rothman. Polypeptide chain binding proteins: catalysts of protein folding and related processes in cells. Cell 59:591–601 (1989).

    Google Scholar 

  3. 3. F. U. Hartl. Molecular chaperones in cellular protein folding. Nature 381:571–579 (1996).

    Article  CAS  PubMed  Google Scholar 

  4. 4. Y. Moroi, M. Mayhew, J. Trcka, M. H. Hoe, Y. Takechi, F. U. Hartl, J. E. Rothman, and A. N. Houghton. Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70. Proc. Natl. Acad. Sci. USA 97:3485–3490 (2000).

    Google Scholar 

  5. 5. H. Udono and P. K. Srivastava. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol. 152:5398–5403 (1994).

    Google Scholar 

  6. 6. C. Gross, D. Hansch, R. Gastpar, and G. Multhoff. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol. Chem. 384:267–279 (2003).

    Google Scholar 

  7. 7. P. Srivastava. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20:395–425 (2002).

    Google Scholar 

  8. 8. S. Somersan, M. Larsson, J. F. Fonteneau, S. Basu, P. Srivastava, and N. Bhardwaj. Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J. Immunol. 167:4844–4852 (2001).

    Google Scholar 

  9. 9. S. Basu, R. J. Binder, R. Suto, K. M. Anderson, and P. K. Srivastava. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12:1539–1546 (2000).

    Google Scholar 

  10. 10. J. Herz and D. K. Strickland. LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108:779–784 (2001).

    Google Scholar 

  11. 11. R. J. Binder, D. K. Han, and P. K. Srivastava. CD91: a receptor for heat shock protein gp96. Nat. Immunol. 1:151–155 (2000).

    Google Scholar 

  12. 12. Y. Delneste, G. Magistrelli, J. Gauchat, J. Haeuw, J. Aubry, K. Nakamura, N. Kawakami-Honda, L. Goetsch, T. Sawamura, J. Bonnefoy, and P. Jeannin. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17:353–362 (2002).

    Article  CAS  PubMed  Google Scholar 

  13. 13. G. Draude, N. Hrboticky, and R. L. Lorenz. The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin. Biochem. Pharmacol. 57:383–386 (1999).

    Google Scholar 

  14. 14. C. T. Chu and S. V. Pizzo. Receptor-mediated antigen delivery into macrophages. Complexing antigen to alpha 2-macroglobulin enhances presentation to T cells. J. Immunol. 150:48–58 (1993).

    Google Scholar 

  15. 15. D. J. Hnatowich, W. W. Layne, and R. L. Childs. The preparation and labeling of DTPA-coupled albumin. Int. J. Appl. Radiat. Isot. 33:327–332 (1982).

    Google Scholar 

  16. 16. J. R. Duncan and M. J. Welch. Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins. J. Nucl. Med. 34:1728–1738 (1993).

    Google Scholar 

  17. 17. Y. Arano, T. Mukai, T. Uezono, K. Wakisaka, H. Motonari, H. Akizawa, Y. Taoka, and A. Yokoyama. A biological method to evaluate bifunctional chelating agents to label antibodies with metallic radionuclides. J. Nucl. Med. 35:890–898 (1994).

    Google Scholar 

  18. 18. R. Blomhoff, H. K. Blomhoff, H. Tolleshaug, T. B. Christensen, and T. Berg. Uptake and degradation of bovine testes beta-galactosidase by parenchymal and nonparenchymal rat liver cells. Int. J. Biochem. 17:1321–1328 (1985).

    Google Scholar 

  19. 19. K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (multi) for microcomputer. J. Pharmacobiodyn. 4:879–885 (1981).

    Google Scholar 

  20. 20. M. Nishikawa, S. Takemura, Y. Takakura, and M. Hashida. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. J. Pharmacol. Exp. Ther. 287:408–415 (1998).

    Google Scholar 

  21. 21. P. K. Srivastava. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens. Methods 12:165–171 (1997).

    Google Scholar 

  22. 22. M. Graner, A. Raymond, E. Akporiaye, and E. Katsanis. Tumor-derived multiple chaperone enrichment by free-solution isoelectric focusing yields potent antitumor vaccines. Cancer Immunol. Immunother. 49:476–484 (2000).

    Google Scholar 

  23. 23. R. Abraham, N. Singh, A. Mukhopadhyay, S. K. Basu, V. Bal, and S. Rath. Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages. J. Immunol. 154:1–8 (1995).

    Google Scholar 

  24. 24. S. Basu, R. J. Binder, T. Ramalingam, and P. K. Srivastava. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303–313 (2001).

    Article  CAS  PubMed  Google Scholar 

  25. 25. Y. Yamasaki, K. Sumimoto, M. Nishikawa, F. Yamashita, K. Yamaoka, M. Hashida, and Y. Takakura. Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors. J. Pharmacol. Exp. Ther. 301:467–477 (2002).

    Google Scholar 

  26. 26. D. K. Strickland, J. D. Ashcom, S. Williams, W. H. Burgess, M. Migliorini, and W. S. Argraves. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265:17401–17404 (1990).

    Google Scholar 

  27. 27. R. W. Jansen, P. Olinga, G. Harms, and D. K. Meijer. Pharmacokinetic analysis and cellular distribution of the anti-HIV compound succinylated human serum albumin (Suc-HSA) in vivo and in the isolated perfused rat liver. Pharm. Res. 10:1611–1614 (1993).

    Google Scholar 

  28. 28. M. E. Kuipers, P. J. Swart, M. Schutten, C. Smit, J. H. Proost, A. D. Osterhaus, and D. K. Meijer. Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice. Antiviral Res. 33:99–108 (1997).

    Google Scholar 

  29. 29. Y. Yamasaki, K. Sumimoto, M. Nishikawa, F. Yamashita, K. Yamaoka, M. Hashida, and Y. Takakura. Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors. J. Pharmacol. Exp. Ther. 301:467–477 (2002).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshinobu Takakura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takemoto, S., Nishikawa, M. & Takakura, Y. Pharmacokinetic and Tissue Distribution Mechanism of Mouse Recombinant Heat Shock Protein 70 in Mice. Pharm Res 22, 419–426 (2005). https://doi.org/10.1007/s11095-004-1880-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-004-1880-0

Key Words:

Navigation